Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monopar Therapeutics (MNPR) Current Assets (2016 - 2020)

Historic Current Assets for Monopar Therapeutics (MNPR) over the last 5 years, with Q3 2020 value amounting to $18.1 million.

  • Monopar Therapeutics' Current Assets rose 25405.29% to $18.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was $18.1 million, marking a year-over-year increase of 25405.29%. This contributed to the annual value of $13.2 million for FY2019, which is 8242.18% up from last year.
  • According to the latest figures from Q3 2020, Monopar Therapeutics' Current Assets is $18.1 million, which was up 25405.29% from $12.7 million recorded in Q2 2020.
  • In the past 5 years, Monopar Therapeutics' Current Assets registered a high of $18.1 million during Q3 2020, and its lowest value of $2.1 million during Q4 2016.
  • Moreover, its 5-year median value for Current Assets was $7.9 million (2018), whereas its average is $8.9 million.
  • Per our database at Business Quant, Monopar Therapeutics' Current Assets surged by 33582.25% in 2017 and then crashed by 3523.37% in 2019.
  • Quarter analysis of 5 years shows Monopar Therapeutics' Current Assets stood at $2.1 million in 2016, then surged by 335.82% to $9.1 million in 2017, then dropped by 20.58% to $7.3 million in 2018, then surged by 82.42% to $13.2 million in 2019, then skyrocketed by 36.72% to $18.1 million in 2020.
  • Its Current Assets stands at $18.1 million for Q3 2020, versus $12.7 million for Q2 2020 and $12.7 million for Q1 2020.